

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ncRNA 3-end processing (GO:0043628) | 8.86799734 |
| 2 | skeletal muscle tissue regeneration (GO:0043403) | 7.12793274 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 7.10775709 |
| 4 | negative regulation of muscle hypertrophy (GO:0014741) | 7.09438770 |
| 5 | muscle filament sliding (GO:0030049) | 6.78067926 |
| 6 | actin-myosin filament sliding (GO:0033275) | 6.78067926 |
| 7 | response to muscle activity (GO:0014850) | 6.45137876 |
| 8 | negative regulation of skeletal muscle tissue development (GO:0048642) | 6.37642612 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 6.37589483 |
| 10 | protein K6-linked ubiquitination (GO:0085020) | 5.88479794 |
| 11 | actin-mediated cell contraction (GO:0070252) | 5.47019037 |
| 12 | neuronal action potential propagation (GO:0019227) | 5.32373352 |
| 13 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 4.96355985 |
| 14 | gamma-aminobutyric acid transport (GO:0015812) | 4.95377408 |
| 15 | cellular response to dexamethasone stimulus (GO:0071549) | 4.67239613 |
| 16 | positive regulation of mitochondrial fission (GO:0090141) | 4.59126426 |
| 17 | response to activity (GO:0014823) | 4.53644439 |
| 18 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.40293068 |
| 19 | coenzyme catabolic process (GO:0009109) | 4.35061086 |
| 20 | response to dexamethasone (GO:0071548) | 4.30464399 |
| 21 | striated muscle adaptation (GO:0014888) | 4.28281061 |
| 22 | viral transcription (GO:0019083) | 4.17151159 |
| 23 | regulation of protein polyubiquitination (GO:1902914) | 4.05273056 |
| 24 | translational elongation (GO:0006414) | 3.98577854 |
| 25 | myotube cell development (GO:0014904) | 3.97301816 |
| 26 | translational termination (GO:0006415) | 3.94815032 |
| 27 | protein-cofactor linkage (GO:0018065) | 3.93034851 |
| 28 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.87441818 |
| 29 | regulation of gene silencing by RNA (GO:0060966) | 3.87218748 |
| 30 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.87218748 |
| 31 | regulation of gene silencing by miRNA (GO:0060964) | 3.87218748 |
| 32 | ubiquinone biosynthetic process (GO:0006744) | 3.81960468 |
| 33 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.75216616 |
| 34 | skeletal muscle fiber development (GO:0048741) | 3.74983163 |
| 35 | actin filament-based movement (GO:0030048) | 3.70952308 |
| 36 | muscle adaptation (GO:0043500) | 3.70155733 |
| 37 | regulation of muscle hypertrophy (GO:0014743) | 3.69665397 |
| 38 | skeletal muscle contraction (GO:0003009) | 3.58832966 |
| 39 | cellular protein complex localization (GO:0034629) | 3.47500552 |
| 40 | regulation of activin receptor signaling pathway (GO:0032925) | 3.46943930 |
| 41 | embryonic foregut morphogenesis (GO:0048617) | 3.45007908 |
| 42 | cellular sodium ion homeostasis (GO:0006883) | 3.43493069 |
| 43 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.43318637 |
| 44 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.39469869 |
| 45 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.39073507 |
| 46 | protein targeting to ER (GO:0045047) | 3.33322546 |
| 47 | axoneme assembly (GO:0035082) | 3.33099401 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.30568136 |
| 49 | rRNA methylation (GO:0031167) | 3.29420862 |
| 50 | regulation of histone H3-K9 methylation (GO:0051570) | 3.27111496 |
| 51 | regulation of relaxation of muscle (GO:1901077) | 3.26390711 |
| 52 | ubiquinone metabolic process (GO:0006743) | 3.23739889 |
| 53 | quinone biosynthetic process (GO:1901663) | 3.23029292 |
| 54 | protein localization to endoplasmic reticulum (GO:0070972) | 3.22061613 |
| 55 | base-excision repair, AP site formation (GO:0006285) | 3.19342262 |
| 56 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.19295024 |
| 57 | pyrimidine dimer repair (GO:0006290) | 3.18450791 |
| 58 | viral life cycle (GO:0019058) | 3.17410260 |
| 59 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.14605435 |
| 60 | regulation of alkaline phosphatase activity (GO:0010692) | 3.12417738 |
| 61 | G-protein coupled receptor internalization (GO:0002031) | 3.08758078 |
| 62 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.05750256 |
| 63 | regulation of centrosome duplication (GO:0010824) | 3.03786879 |
| 64 | positive regulation of fatty acid oxidation (GO:0046321) | 3.02327352 |
| 65 | regulation of mitochondrial fission (GO:0090140) | 3.02008624 |
| 66 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 3.00043371 |
| 67 | negative regulation of organelle assembly (GO:1902116) | 2.99684850 |
| 68 | response to electrical stimulus (GO:0051602) | 2.95909242 |
| 69 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.95422889 |
| 70 | regulation of DNA methylation (GO:0044030) | 2.94285108 |
| 71 | DNA synthesis involved in DNA repair (GO:0000731) | 2.93946895 |
| 72 | cellular protein complex disassembly (GO:0043624) | 2.90606901 |
| 73 | dicarboxylic acid catabolic process (GO:0043649) | 2.89870686 |
| 74 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.89052136 |
| 75 | rRNA modification (GO:0000154) | 2.85194132 |
| 76 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.84114066 |
| 77 | ganglion development (GO:0061548) | 2.83671012 |
| 78 | muscle organ development (GO:0007517) | 2.81629466 |
| 79 | negative regulation of protein acetylation (GO:1901984) | 2.76411489 |
| 80 | negative regulation of gene silencing (GO:0060969) | 2.75753245 |
| 81 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.74953825 |
| 82 | muscle structure development (GO:0061061) | 2.73144615 |
| 83 | regulation of stem cell maintenance (GO:2000036) | 2.72062821 |
| 84 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.68526624 |
| 85 | dopamine transport (GO:0015872) | 2.61789579 |
| 86 | branch elongation of an epithelium (GO:0060602) | 2.59344600 |
| 87 | anterograde synaptic vesicle transport (GO:0048490) | 2.55912264 |
| 88 | translational initiation (GO:0006413) | 2.55613629 |
| 89 | ovulation from ovarian follicle (GO:0001542) | 2.55187698 |
| 90 | mitochondrion distribution (GO:0048311) | 2.52425580 |
| 91 | anterior/posterior axis specification, embryo (GO:0008595) | 2.50861089 |
| 92 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.50550269 |
| 93 | positive regulation of cholesterol efflux (GO:0010875) | 2.48414070 |
| 94 | cofactor catabolic process (GO:0051187) | 2.47238949 |
| 95 | dosage compensation (GO:0007549) | 2.46320282 |
| 96 | regulation of hexokinase activity (GO:1903299) | 2.45374544 |
| 97 | skeletal muscle adaptation (GO:0043501) | 10.7165318 |
| 98 | striated muscle atrophy (GO:0014891) | 10.5676181 |
| 99 | muscle atrophy (GO:0014889) | 10.2085273 |
| 100 | response to gravity (GO:0009629) | 10.1685313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.17458792 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.24303152 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.44855853 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.44855853 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.44855853 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.36480147 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22781028 |
| 8 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.85594211 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.61047476 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.23008956 |
| 11 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.02898179 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01242230 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 12.5743740 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 12.3089534 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93640902 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37433683 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35287701 |
| 18 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.28096465 |
| 19 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25193247 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22398399 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20696106 |
| 22 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14053888 |
| 23 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12934498 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11173808 |
| 25 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10940601 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09879993 |
| 27 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99772446 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96233848 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90241038 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88179473 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 0.85005823 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83844441 |
| 33 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83711101 |
| 34 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.83427141 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83187090 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.83165094 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.83165094 |
| 38 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.80502032 |
| 39 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.80001869 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79977143 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.79287926 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77361018 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.72700444 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.72480395 |
| 45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71631097 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.71431596 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69503408 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68578949 |
| 49 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.68173278 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.67882280 |
| 51 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.67088031 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 0.66844302 |
| 53 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.65757675 |
| 54 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.65308297 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.65208997 |
| 56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.64814398 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 0.64626582 |
| 58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.63474127 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.62622238 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.61460698 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.60751074 |
| 62 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60742677 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.60512704 |
| 64 | SA1_27219007_Chip-Seq_Bcells_Human | 0.59841525 |
| 65 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.57607238 |
| 66 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.57542414 |
| 67 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.55848509 |
| 68 | KDM2B_26808549_Chip-Seq_REH_Human | 0.55311960 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.54134858 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.53550925 |
| 71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.53091770 |
| 72 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.50148522 |
| 73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.50058343 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.50058343 |
| 75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.49428907 |
| 76 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.49286038 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.48355596 |
| 78 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.47755539 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.47467366 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.46648991 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.46636429 |
| 82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.46447360 |
| 83 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.46253125 |
| 84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.46129522 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.45289549 |
| 86 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.45103598 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.43698930 |
| 88 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.43624291 |
| 89 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42721130 |
| 90 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.41655663 |
| 91 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.40432936 |
| 92 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.39748190 |
| 93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.39182340 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.38829902 |
| 95 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.38427158 |
| 96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.38079797 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.37697856 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.37451623 |
| 99 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.37162143 |
| 100 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.37100126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.06336728 |
| 2 | MP0000747_muscle_weakness | 4.28512066 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.19482672 |
| 4 | MP0000015_abnormal_ear_pigmentation | 4.05870042 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.21231958 |
| 6 | MP0008057_abnormal_DNA_replication | 2.99741673 |
| 7 | MP0004133_heterotaxia | 2.73881490 |
| 8 | MP0002277_abnormal_respiratory_mucosa | 2.61275767 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 2.60599725 |
| 10 | MP0002095_abnormal_skin_pigmentation | 2.59458725 |
| 11 | MP0002269_muscular_atrophy | 2.49674737 |
| 12 | MP0002108_abnormal_muscle_morphology | 2.38566270 |
| 13 | MP0002928_abnormal_bile_duct | 2.37086325 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.34283596 |
| 15 | MP0000751_myopathy | 2.34150936 |
| 16 | MP0000749_muscle_degeneration | 2.30000684 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.28726485 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.19034843 |
| 19 | MP0000566_synostosis | 2.18112182 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.10380359 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 2.04580528 |
| 22 | MP0005275_abnormal_skin_tensile | 1.99984264 |
| 23 | MP0003879_abnormal_hair_cell | 1.96078683 |
| 24 | MP0003938_abnormal_ear_development | 1.95593282 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 1.92182315 |
| 26 | MP0003878_abnormal_ear_physiology | 1.92182315 |
| 27 | MP0002089_abnormal_postnatal_growth/wei | 1.82630673 |
| 28 | MP0002106_abnormal_muscle_physiology | 1.82427185 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.82406781 |
| 30 | MP0005620_abnormal_muscle_contractility | 1.70322033 |
| 31 | MP0005670_abnormal_white_adipose | 1.67590802 |
| 32 | MP0003045_fibrosis | 1.65660986 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.50753540 |
| 34 | MP0005499_abnormal_olfactory_system | 1.50590192 |
| 35 | MP0005394_taste/olfaction_phenotype | 1.50590192 |
| 36 | MP0004885_abnormal_endolymph | 1.47373191 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.46217624 |
| 38 | MP0005369_muscle_phenotype | 1.44205986 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.42029506 |
| 40 | MP0001270_distended_abdomen | 1.40885616 |
| 41 | MP0004130_abnormal_muscle_cell | 1.37617814 |
| 42 | MP0005083_abnormal_biliary_tract | 1.34933680 |
| 43 | MP0002177_abnormal_outer_ear | 1.24233806 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.23370162 |
| 45 | MP0003303_peritoneal_inflammation | 1.21721909 |
| 46 | MP0001905_abnormal_dopamine_level | 1.18974687 |
| 47 | MP0009379_abnormal_foot_pigmentation | 1.18238200 |
| 48 | MP0003959_abnormal_lean_body | 1.16601290 |
| 49 | MP0004233_abnormal_muscle_weight | 1.10732149 |
| 50 | MP0001873_stomach_inflammation | 1.10404312 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.08492505 |
| 52 | MP0002098_abnormal_vibrissa_morphology | 1.05613166 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.04643002 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 0.99481621 |
| 55 | MP0006035_abnormal_mitochondrial_morpho | 0.99437932 |
| 56 | MP0000049_abnormal_middle_ear | 0.98205369 |
| 57 | MP0003937_abnormal_limbs/digits/tail_de | 0.97623686 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 0.96818718 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 0.96566413 |
| 60 | MP0003943_abnormal_hepatobiliary_system | 0.94904926 |
| 61 | MP0005409_darkened_coat_color | 0.93554667 |
| 62 | MP0009053_abnormal_anal_canal | 0.93508147 |
| 63 | MP0004142_abnormal_muscle_tone | 0.93392981 |
| 64 | MP0005334_abnormal_fat_pad | 0.93255437 |
| 65 | MP0000538_abnormal_urinary_bladder | 0.93211926 |
| 66 | MP0002736_abnormal_nociception_after | 0.91502883 |
| 67 | MP0005408_hypopigmentation | 0.91448199 |
| 68 | MP0000427_abnormal_hair_cycle | 0.91112099 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 0.87929178 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.87831073 |
| 71 | MP0001881_abnormal_mammary_gland | 0.87764874 |
| 72 | MP0001346_abnormal_lacrimal_gland | 0.86596205 |
| 73 | MP0000762_abnormal_tongue_morphology | 0.78250478 |
| 74 | MP0000750_abnormal_muscle_regeneration | 0.75839885 |
| 75 | MP0002075_abnormal_coat/hair_pigmentati | 0.75544734 |
| 76 | MP0002938_white_spotting | 0.75094529 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.73883305 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.72065165 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.70654573 |
| 80 | MP0009250_abnormal_appendicular_skeleto | 0.69889125 |
| 81 | MP0000733_abnormal_muscle_development | 0.68931239 |
| 82 | MP0002971_abnormal_brown_adipose | 0.68778846 |
| 83 | MP0001968_abnormal_touch/_nociception | 0.68186670 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.67654599 |
| 85 | MP0003880_abnormal_central_pattern | 0.66055853 |
| 86 | MP0009278_abnormal_bone_marrow | 0.61338273 |
| 87 | MP0000579_abnormal_nail_morphology | 0.60555814 |
| 88 | MP0006292_abnormal_olfactory_placode | 0.58588754 |
| 89 | MP0002114_abnormal_axial_skeleton | 0.54578916 |
| 90 | MP0003186_abnormal_redox_activity | 0.53832043 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.53414331 |
| 92 | MP0004270_analgesia | 0.51461326 |
| 93 | MP0000627_abnormal_mammary_gland | 0.50746448 |
| 94 | MP0003119_abnormal_digestive_system | 0.50382180 |
| 95 | MP0002069_abnormal_eating/drinking_beha | 0.47391889 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.45946655 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.45895936 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.45736940 |
| 99 | MP0000467_abnormal_esophagus_morphology | 0.44914086 |
| 100 | MP0000537_abnormal_urethra_morphology | 0.43819758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 6.45796428 |
| 2 | Mask-like facies (HP:0000298) | 6.15178107 |
| 3 | Albinism (HP:0001022) | 5.49843372 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.44563500 |
| 5 | Distal arthrogryposis (HP:0005684) | 5.15450303 |
| 6 | Myopathic facies (HP:0002058) | 5.14790265 |
| 7 | Myotonia (HP:0002486) | 5.10760691 |
| 8 | Nemaline bodies (HP:0003798) | 4.76298749 |
| 9 | Absent phalangeal crease (HP:0006109) | 4.45930750 |
| 10 | Split foot (HP:0001839) | 4.37510738 |
| 11 | Exercise-induced myalgia (HP:0003738) | 4.37079123 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 4.20872152 |
| 13 | Hypokinesia (HP:0002375) | 4.19788744 |
| 14 | Round ear (HP:0100830) | 4.04645591 |
| 15 | 3-Methylglutaconic aciduria (HP:0003535) | 3.93110313 |
| 16 | Metaphyseal dysplasia (HP:0100255) | 3.92184301 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 3.91912057 |
| 18 | Potter facies (HP:0002009) | 3.87214131 |
| 19 | Facial shape deformation (HP:0011334) | 3.87214131 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 3.83952268 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.81888398 |
| 22 | Deformed tarsal bones (HP:0008119) | 3.70558381 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 3.68372686 |
| 24 | Absent hand (HP:0004050) | 3.51500377 |
| 25 | Hyperkalemia (HP:0002153) | 3.50073065 |
| 26 | Abnormality of the fingertips (HP:0001211) | 3.24392027 |
| 27 | Muscle stiffness (HP:0003552) | 3.23870971 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.21577981 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.21577981 |
| 30 | Periorbital edema (HP:0100539) | 3.18855030 |
| 31 | Neoplasm of the heart (HP:0100544) | 3.17392369 |
| 32 | Myokymia (HP:0002411) | 3.16252638 |
| 33 | Type 1 muscle fiber predominance (HP:0003803) | 3.15837625 |
| 34 | Abnormality of the parietal bone (HP:0002696) | 3.15725820 |
| 35 | Postural instability (HP:0002172) | 3.14792824 |
| 36 | Hyperphosphatemia (HP:0002905) | 3.12880625 |
| 37 | Short 4th metacarpal (HP:0010044) | 3.08747401 |
| 38 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.08747401 |
| 39 | Supernumerary ribs (HP:0005815) | 3.04720517 |
| 40 | Facial edema (HP:0000282) | 3.04479222 |
| 41 | Stomach cancer (HP:0012126) | 2.96823467 |
| 42 | Down-sloping shoulders (HP:0200021) | 2.89418003 |
| 43 | Childhood onset (HP:0011463) | 2.87457271 |
| 44 | Pancreatic cysts (HP:0001737) | 2.85099499 |
| 45 | Hip dysplasia (HP:0001385) | 2.81186401 |
| 46 | Myoglobinuria (HP:0002913) | 2.80811339 |
| 47 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.76728668 |
| 48 | Methylmalonic acidemia (HP:0002912) | 2.75265135 |
| 49 | Pili torti (HP:0003777) | 2.65746633 |
| 50 | Abnormal drinking behavior (HP:0030082) | 2.64301414 |
| 51 | Polydipsia (HP:0001959) | 2.64301414 |
| 52 | Ulnar claw (HP:0001178) | 2.64291946 |
| 53 | Prolonged QT interval (HP:0001657) | 2.59787725 |
| 54 | Bell-shaped thorax (HP:0001591) | 2.57364969 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.55187361 |
| 56 | Diminished movement (HP:0002374) | 2.49356439 |
| 57 | Cystic liver disease (HP:0006706) | 2.39263126 |
| 58 | Abnormality of the 4th metacarpal (HP:0010012) | 2.37458614 |
| 59 | Exercise-induced muscle cramps (HP:0003710) | 2.34570397 |
| 60 | Absent speech (HP:0001344) | 2.34451636 |
| 61 | Viral hepatitis (HP:0006562) | 2.34414408 |
| 62 | Colon cancer (HP:0003003) | 2.31893407 |
| 63 | Increased connective tissue (HP:0009025) | 2.29387641 |
| 64 | Tubulointerstitial fibrosis (HP:0005576) | 2.25444119 |
| 65 | Ocular albinism (HP:0001107) | 2.24290380 |
| 66 | Abnormal hand bone ossification (HP:0010660) | 2.22832624 |
| 67 | Febrile seizures (HP:0002373) | 2.18181456 |
| 68 | Hyporeflexia of lower limbs (HP:0002600) | 2.15728685 |
| 69 | Neonatal respiratory distress (HP:0002643) | 2.12634287 |
| 70 | Abnormal ossification of hand bones (HP:0005921) | 2.10522739 |
| 71 | Metatarsus adductus (HP:0001840) | 2.07141251 |
| 72 | Generalized hypopigmentation (HP:0007513) | 2.03833277 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00901406 |
| 74 | Malignant hyperthermia (HP:0002047) | 1.99687074 |
| 75 | Germ cell neoplasia (HP:0100728) | 1.98157644 |
| 76 | Medulloblastoma (HP:0002885) | 1.96273575 |
| 77 | Scanning speech (HP:0002168) | 1.94718063 |
| 78 | Neck muscle weakness (HP:0000467) | 1.93692392 |
| 79 | Enlarged kidneys (HP:0000105) | 1.93534998 |
| 80 | Iris hypopigmentation (HP:0007730) | 1.91367943 |
| 81 | Neonatal death (HP:0003811) | 1.90152451 |
| 82 | Rhinitis (HP:0012384) | 1.88643147 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 1.86668081 |
| 84 | Decreased circulating renin level (HP:0003351) | 1.85999193 |
| 85 | Exertional dyspnea (HP:0002875) | 1.84933599 |
| 86 | Polyuria (HP:0000103) | 1.83913895 |
| 87 | Difficulty running (HP:0009046) | 1.83404638 |
| 88 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.83227102 |
| 89 | Methylmalonic aciduria (HP:0012120) | 1.81924257 |
| 90 | Ovarian neoplasm (HP:0100615) | 1.80341176 |
| 91 | Microglossia (HP:0000171) | 1.78011437 |
| 92 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.76990844 |
| 93 | Abnormality of potassium homeostasis (HP:0011042) | 1.74422116 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.74153607 |
| 95 | Neoplasm of striated muscle (HP:0009728) | 1.73117862 |
| 96 | Impaired platelet aggregation (HP:0003540) | 1.71403814 |
| 97 | Abnormal platelet function (HP:0011869) | 1.71403814 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 1.70688704 |
| 99 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.70585830 |
| 100 | Nonprogressive disorder (HP:0003680) | 1.67666683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 5.28468104 |
| 2 | PINK1 | 5.05753881 |
| 3 | CASK | 3.85444930 |
| 4 | DYRK3 | 3.34520398 |
| 5 | MELK | 3.34430715 |
| 6 | MAPKAPK3 | 3.17282544 |
| 7 | STK38 | 3.01334217 |
| 8 | NTRK2 | 2.89740729 |
| 9 | PHKG1 | 2.89545295 |
| 10 | PHKG2 | 2.89545295 |
| 11 | OBSCN | 2.79891872 |
| 12 | JAK3 | 2.76464746 |
| 13 | TIE1 | 2.29159231 |
| 14 | FGR | 2.20685859 |
| 15 | TAOK3 | 2.19652757 |
| 16 | EIF2AK1 | 2.01707506 |
| 17 | ABL2 | 1.94543290 |
| 18 | TYRO3 | 1.92287211 |
| 19 | TLK1 | 1.70088206 |
| 20 | CDK8 | 1.58819772 |
| 21 | PAK6 | 1.58776222 |
| 22 | STK16 | 1.35668431 |
| 23 | OXSR1 | 1.35314820 |
| 24 | WNK4 | 1.33240319 |
| 25 | TAOK1 | 1.32216238 |
| 26 | PIK3CA | 1.30287685 |
| 27 | SCYL2 | 1.24631465 |
| 28 | WNK1 | 1.21521191 |
| 29 | IRAK1 | 1.14196854 |
| 30 | DMPK | 1.09800215 |
| 31 | NEK6 | 1.07188561 |
| 32 | SGK2 | 1.06393899 |
| 33 | MKNK2 | 1.05052471 |
| 34 | STK4 | 1.03952152 |
| 35 | CDK19 | 0.98132654 |
| 36 | NLK | 0.96495907 |
| 37 | CAMK2G | 0.94188538 |
| 38 | FGFR2 | 0.92431884 |
| 39 | CDK4 | 0.89623530 |
| 40 | MAPK7 | 0.87333262 |
| 41 | SGK3 | 0.84329597 |
| 42 | MAPK13 | 0.75157466 |
| 43 | CDC7 | 0.75099349 |
| 44 | MARK1 | 0.70599056 |
| 45 | STK39 | 0.69308221 |
| 46 | RPS6KB2 | 0.66717338 |
| 47 | SGK1 | 0.65288766 |
| 48 | RPS6KA5 | 0.65247533 |
| 49 | DYRK1A | 0.64283837 |
| 50 | MAPK12 | 0.62210726 |
| 51 | EPHA2 | 0.61936044 |
| 52 | SGK223 | 0.60666040 |
| 53 | SGK494 | 0.60666040 |
| 54 | CSNK1G1 | 0.58888025 |
| 55 | CCNB1 | 0.58017123 |
| 56 | RPS6KA4 | 0.53586587 |
| 57 | SMG1 | 0.53080766 |
| 58 | PASK | 0.52725879 |
| 59 | RPS6KA2 | 0.51635920 |
| 60 | RPS6KL1 | 0.50485892 |
| 61 | RPS6KC1 | 0.50485892 |
| 62 | IKBKE | 0.48944675 |
| 63 | TGFBR1 | 0.48885188 |
| 64 | TXK | 0.48570643 |
| 65 | PRKG1 | 0.48406936 |
| 66 | BMPR1B | 0.48268899 |
| 67 | FRK | 0.47945886 |
| 68 | CLK1 | 0.46501969 |
| 69 | RPS6KA6 | 0.46104801 |
| 70 | NME2 | 0.45644255 |
| 71 | MUSK | 0.45639963 |
| 72 | EPHB2 | 0.44635888 |
| 73 | CAMKK2 | 0.42265110 |
| 74 | PKN1 | 0.41849981 |
| 75 | FES | 0.41448680 |
| 76 | PRKD2 | 0.39092110 |
| 77 | PAK3 | 0.39059835 |
| 78 | PIK3CG | 0.34188130 |
| 79 | CDK5 | 0.33662691 |
| 80 | RPS6KA1 | 0.33262949 |
| 81 | STK11 | 0.31680247 |
| 82 | PRKACA | 0.30334451 |
| 83 | HIPK2 | 0.26777710 |
| 84 | ABL1 | 0.23561058 |
| 85 | PDPK1 | 0.23510038 |
| 86 | INSRR | 0.22851973 |
| 87 | CAMK2D | 0.22321181 |
| 88 | CAMK1D | 0.21155407 |
| 89 | PRKACB | 0.20936108 |
| 90 | TEC | 0.20179046 |
| 91 | RPS6KA3 | 0.20044384 |
| 92 | PRKACG | 0.19741884 |
| 93 | CAMK4 | 0.18819060 |
| 94 | MAPKAPK2 | 0.18149682 |
| 95 | CDK18 | 0.17257059 |
| 96 | FGFR1 | 0.16489468 |
| 97 | CDK15 | 0.16443261 |
| 98 | IKBKB | 0.15868433 |
| 99 | CSNK1A1 | 0.15859488 |
| 100 | ADRBK2 | 0.14108759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.16209219 |
| 2 | Tight junction_Homo sapiens_hsa04530 | 3.68112388 |
| 3 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 3.27065301 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.73664533 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.73136112 |
| 6 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.56306978 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.39712973 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.23919903 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16018093 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98932141 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95218100 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.91465048 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87680127 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69672790 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65317402 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56770995 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54839149 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50930126 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48926123 |
| 20 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.42470617 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42440840 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39495317 |
| 23 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.38394375 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27221252 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.26607572 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24545292 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22894481 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20868961 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20153619 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13084454 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12983667 |
| 32 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.12028019 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10061336 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.02895750 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02768146 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01980253 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01337310 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.01191677 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95721395 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95180895 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94614055 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91967167 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.91817296 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90706578 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89461929 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89313848 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85246921 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83101998 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81916065 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79508876 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77906268 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74105781 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73525247 |
| 54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73072698 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71304888 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.67527775 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67394660 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65912785 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65365761 |
| 60 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61610708 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61364446 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61352872 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61257784 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60254529 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.59735527 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58921371 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58898704 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57710343 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56236865 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55649555 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55298273 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55172390 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54319876 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53579900 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53468544 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.52928378 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52872658 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52141238 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.50160347 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.49116280 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48686793 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48477879 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48266507 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46039366 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45433667 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43953152 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43606049 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.43426863 |
| 89 | RNA polymerase_Homo sapiens_hsa03020 | 0.41103678 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39490351 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37853016 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37243093 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32876638 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.32567794 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31743972 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.31305773 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30794064 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28141948 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28001906 |
| 100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27242524 |

